Učitavanje...
Trial watch: TLR3 agonists in cancer therapy
Toll-like receptor 3 (TLR3) is a pattern recognition receptor that senses exogenous (viral) as well as endogenous (mammalian) double-stranded RNA in endosomes. On activation, TLR3 initiates a signal transduction pathway that culminates with the secretion of pro-inflammatory cytokines including type...
Spremljeno u:
| Izdano u: | Oncoimmunology |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466857/ https://ncbi.nlm.nih.gov/pubmed/32934877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1771143 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|